Importantly, diastolic dysfunction was ameliorated by inhibition of TGFβ in experimental T2DM, suggesting a central role of TGFβ-signalling in DCM pathogeny [135]. This evidence concerns the gene TGFB1 and type 2 diabetes mellitus.